365 related articles for article (PubMed ID: 7510345)
1. Somatic allelic loss at the DCC, APC, nm23-H1 and p53 tumor suppressor gene loci in human prostatic carcinoma.
Brewster SF; Browne S; Brown KW
J Urol; 1994 Apr; 151(4):1073-7. PubMed ID: 7510345
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of the loss of heterozygosity of Nm23-H1 and p53 genes in human colorectal carcinomas.
Campo E; Miquel R; Jares P; Bosch F; Juan M; Leone A; Vives J; Cardesa A; Yague J
Cancer; 1994 Jun; 73(12):2913-21. PubMed ID: 8199988
[TBL] [Abstract][Full Text] [Related]
3. Frequency of allele loss of DCC, p53, RBI, WT1, NF1, NM23 and APC/MCC in colorectal cancer assayed by fluorescent multiplex polymerase chain reaction.
Cawkwell L; Lewis FA; Quirke P
Br J Cancer; 1994 Nov; 70(5):813-8. PubMed ID: 7947085
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.
Gao X; Porter AT; Honn KV
Adv Exp Med Biol; 1997; 407():41-53. PubMed ID: 9321930
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity of tumour suppressor gene loci in human colorectal carcinoma.
Iacopetta B; DiGrandi S; Dix B; Haig C; Soong R; House A
Eur J Cancer; 1994; 30A(5):664-70. PubMed ID: 8080684
[TBL] [Abstract][Full Text] [Related]
6. Use of crypt isolation to determine loss of heterozygosity of multiple tumor suppressor genes in colorectal carcinoma.
Sugai T; Habano W; Nakamura S; Yoshida T; Uesugi N; Sasou S; Itoh C; Katoh R
Pathol Res Pract; 2000; 196(3):145-50. PubMed ID: 10729918
[TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity at the p53, RB, DCC and APC tumor suppressor gene loci in human bladder cancer.
Miyamoto H; Shuin T; Ikeda I; Hosaka M; Kubota Y
J Urol; 1996 Apr; 155(4):1444-7. PubMed ID: 8632608
[TBL] [Abstract][Full Text] [Related]
8. Suppressive role of the metastasis-related nm23-H1 gene in human ovarian carcinomas: association of high messenger RNA expression with lack of lymph node metastasis.
Viel A; Dall'Agnese L; Canzonieri V; Sopracordevole F; Capozzi E; Carbone A; Visentin MC; Boiocchi M
Cancer Res; 1995 Jun; 55(12):2645-50. PubMed ID: 7780979
[TBL] [Abstract][Full Text] [Related]
9. Allelic analysis of serous ovarian carcinoma reveals two putative tumor suppressor loci at 18q22-q23 distal to SMAD4, SMAD2, and DCC.
Lassus H; Salovaara R; Aaltonen LA; Butzow R
Am J Pathol; 2001 Jul; 159(1):35-42. PubMed ID: 11438451
[TBL] [Abstract][Full Text] [Related]
10. Allele loss from 5q21 (APC/MCC) and 18q21 (DCC) and DCC mRNA expression in breast cancer.
Thompson AM; Morris RG; Wallace M; Wyllie AH; Steel CM; Carter DC
Br J Cancer; 1993 Jul; 68(1):64-8. PubMed ID: 8318422
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity of multiple tumor suppressor genes in human gastric cancers by polymerase chain reaction.
Cho JH; Noguchi M; Ochiai A; Hirohashi S
Lab Invest; 1996 Apr; 74(4):835-41. PubMed ID: 8606493
[TBL] [Abstract][Full Text] [Related]
12. Somatic allelic deletion of nm23 in human cancer.
Leone A; McBride OW; Weston A; Wang MG; Anglard P; Cropp CS; Goepel JR; Lidereau R; Callahan R; Linehan WM
Cancer Res; 1991 May; 51(9):2490-3. PubMed ID: 2015608
[TBL] [Abstract][Full Text] [Related]
13. Observations on tumor and metastatic suppressor gene status in endometrial carcinoma with particular emphasis on p53.
Ambros RA; Vigna PA; Figge J; Kallakury BV; Mastrangelo A; Eastman AY; Malfetano J; Figge HL; Ross JS
Cancer; 1994 Mar; 73(6):1686-92. PubMed ID: 8156496
[TBL] [Abstract][Full Text] [Related]
14. Frequent loss of heterozygosity at the DCC locus in gastric cancer.
Uchino S; Tsuda H; Noguchi M; Yokota J; Terada M; Saito T; Kobayashi M; Sugimura T; Hirohashi S
Cancer Res; 1992 Jun; 52(11):3099-102. PubMed ID: 1591722
[TBL] [Abstract][Full Text] [Related]
15. Malignant mixed tumors of the salivary gland: a study of loss of heterozygosity in tumor suppressor genes.
Fowler MH; Fowler J; Ducatman B; Barnes L; Hunt JL
Mod Pathol; 2006 Mar; 19(3):350-5. PubMed ID: 16400327
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of new microsatellites at the nm23-H1 and nm23-H2 gene loci and application for loss of heterozygosity (LOH) analysis.
Seifert M; Theisinger B; Engel M; Seib T; Seitz G; Stolte M; Hilgert K; Welter C
Hum Genet; 1997 Oct; 100(5-6):515-9. PubMed ID: 9341864
[TBL] [Abstract][Full Text] [Related]
17. Allelotype analysis of esophageal squamous cell carcinoma.
Shibagaki I; Shimada Y; Wagata T; Ikenaga M; Imamura M; Ishizaki K
Cancer Res; 1994 Jun; 54(11):2996-3000. PubMed ID: 8187088
[TBL] [Abstract][Full Text] [Related]
18. Three new regions on chromosome 17p13.3 distal to p53 with possible tumor suppressor gene involvement in lung cancer.
Tsuchiya E; Tanigami A; Ishikawa Y; Nishida K; Hayashi M; Tokuchi Y; Hashimoto T; Okumura S; Tsuchiya S; Nakagawa K
Jpn J Cancer Res; 2000 Jun; 91(6):589-96. PubMed ID: 10874210
[TBL] [Abstract][Full Text] [Related]
19. Tumor progression and loss of heterozygosity at 5q and 18q in non-small cell lung cancer.
Fong KM; Zimmerman PV; Smith PJ
Cancer Res; 1995 Jan; 55(2):220-3. PubMed ID: 7812947
[TBL] [Abstract][Full Text] [Related]
20. [A study on the loss of heterozygosity at the APC/MCC and DCC genetic loci in colorectal cancers].
Lui Y; Fang D; Lu R
Zhonghua Nei Ke Za Zhi; 1996 Jul; 35(7):439-43. PubMed ID: 9592312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
